BALL BRYAN 4
4 · IMMUNOMEDICS INC · Filed Sep 10, 2019
Insider Transaction Report
Form 4
IMMUNOMEDICS INCIMMU
BALL BRYAN
Chief Quality Officer
Transactions
- Award
Stock Option (right to buy)
2019-09-06+57,040→ 57,040 totalExercise: $13.19From: 2020-09-06Exp: 2026-09-06→ Common Stock, par value $0.01 per share (57,040 underlying) - Award
Stock Option (right to buy)
2019-09-10+10,440→ 10,440 totalExercise: $15.59From: 2020-09-10Exp: 2026-09-10→ Common Stock, par value $0.01 per share (10,440 underlying)
Footnotes (1)
- [F1]The reporting person was granted stock options pursuant to the Issuer's 2014 Long-Term Incentive Plan. The stock options vest 25% on the first anniversary of the date of grant, and in 6.25% in equal quarterly installments over a three-year period thereafter.